September | 2026
Acandis is proud to announce the completion of its merger with Angionautix, the Spain- and Latin
America-based neurovascular distribution specialist.
Joining forces with Acandis opens a new frontier for Angionautix. With access to a broader product portfolio, deeper R&D capabilities, and a European operational backbone, the Angionautix team will be better equipped than ever to serve its markets and its patients. For Acandis, Angionautix unlocks a meaningful and immediate presence in some of the world’s most dynamic markets for neurovascular care.
We are delighted to welcome the entire Angionautix team to the Acandis family and look forward to building the future together.
Further information:
Download the full press release here.